- Home
- LFCR vs SPXX Comparison
LFCR vs SPXX Comparison
Compare LFCR & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- SPXX
- Stock Information
- Founded
- LFCR 1986
- SPXX 2004
- Country
- LFCR United States
- SPXX United States
- Employees
- LFCR N/A
- SPXX N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- SPXX Trusts Except Educational Religious and Charitable
- Sector
- LFCR Health Care
- SPXX Finance
- Exchange
- LFCR Nasdaq
- SPXX Nasdaq
- Market Cap
- LFCR 308.8M
- SPXX 322.7M
- IPO Year
- LFCR N/A
- SPXX N/A
- Fundamental
- Price
- LFCR $7.61
- SPXX $18.09
- Analyst Decision
- LFCR Buy
- SPXX
- Analyst Count
- LFCR 4
- SPXX 0
- Target Price
- LFCR $8.00
- SPXX N/A
- AVG Volume (30 Days)
- LFCR 108.3K
- SPXX 51.3K
- Earning Date
- LFCR 08-07-2025
- SPXX 01-01-0001
- Dividend Yield
- LFCR N/A
- SPXX 7.55%
- EPS Growth
- LFCR N/A
- SPXX N/A
- EPS
- LFCR N/A
- SPXX N/A
- Revenue
- LFCR $128,867,000.00
- SPXX N/A
- Revenue This Year
- LFCR $4.78
- SPXX N/A
- Revenue Next Year
- LFCR $12.02
- SPXX N/A
- P/E Ratio
- LFCR N/A
- SPXX N/A
- Revenue Growth
- LFCR 0.47
- SPXX N/A
- 52 Week Low
- LFCR $3.68
- SPXX $13.57
- 52 Week High
- LFCR $8.85
- SPXX $16.05
- Technical
- Relative Strength Index (RSI)
- LFCR 53.94
- SPXX 57.76
- Support Level
- LFCR $7.33
- SPXX $17.73
- Resistance Level
- LFCR $7.73
- SPXX $18.20
- Average True Range (ATR)
- LFCR 0.30
- SPXX 0.15
- MACD
- LFCR 0.03
- SPXX -0.00
- Stochastic Oscillator
- LFCR 65.33
- SPXX 76.60
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35%-75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.